Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Res ; 1663: 166-173, 2017 05 15.
Article in English | MEDLINE | ID: mdl-28288870

ABSTRACT

Transient ischemic attack (TIA) has received only little attention in the experimental research field. Recently, we introduced a TIA model for mice, and here we set similar principles for simulating this human condition in Wistar rats. In the model: 1) transient nature of the event is ensured, and 2) 24h after the event animals are free from any sensorimotor deficit and from any detectable lesion by magnetic resonance imaging (MRI). Animals experienced varying durations of ischemia (5, 10, 12.5, 15, 25, and 30min, n=6-8pergroup) by intraluminal middle cerebral artery occlusion (MCAO). Ischemia severity and reperfusion rates were controlled by cerebral blood flow measurements. Sensorimotor neurological evaluations and MRI at 24h differentiated between TIA and ischemic stroke. Hematoxylin and eosin staining and apoptotic cell counts revealed pathological correlates of the event. We found that already 12.5min of ischemia was long enough to induce ischemic stroke in Wistar rats. Ten min or shorter durations induced neither gross neurological deficits nor infarcts visible on MRI, but histologically caused selective neuronal necrosis. A separate group of animals with 10min of ischemia followed up to 1week after reperfusion remained free of infarction and any MRI signal change. Thus, 10min or shorter focal cerebral ischemia induced by intraluminal MCAO in Wistar rats provides a clinically relevant TIA the rat. This model is useful for studying molecular correlates of TIA.


Subject(s)
Brain Ischemia/pathology , Disease Models, Animal , Ischemic Attack, Transient/pathology , Animals , Apoptosis , Cerebrovascular Circulation/physiology , Infarction, Middle Cerebral Artery/complications , Ischemic Attack, Transient/veterinary , Male , Necrosis/pathology , Neurons/pathology , Rats , Rats, Wistar , Reperfusion/methods , Stroke/pathology , Time Factors
2.
Neuroscience ; 272: 286-94, 2014 Jul 11.
Article in English | MEDLINE | ID: mdl-24813433

ABSTRACT

Intracerebral hemorrhage (ICH) is the least treatable form of stroke and is associated with the worst prognosis. In up to 40% of cases, ICH is further complicated by intraventricular hemorrhage (IVH), which predisposes to hydrocephalus, and increases case-mortality to 80%. However, IVH is not present in widely used preclinical models of ICH. Here, we characterize a novel rat model of combined ICH and IVH. Rats were injected with different volumes of autologous whole blood into the right deep basal ganglia region (100µL, 150µL, 200µL, and 250µL, n=10 per group). MRI was performed immediately, and at 24, 48, 72h, and 1week after blood injection, along with neurological evaluations. Injected blood volume reliably correlated with blood volumes measured from MRI obtained after blood injection. Brain edema was most prominent in the ⩾200µL groups, peaking at 48h in all groups, being statistically different between the ⩾200µL and <200µL groups at all-time points. Presence of hydrocephalus was detected in most of the animals, most clearly in the 200µL and 250µL groups, both being statistically different from the 100µL group at all-time points, with tendency to worsen during the whole follow-up period. Most deteriorating neurological and behavioral outcomes as well as the highest mortality rates were detected in groups injected with 200µL and 250µL of autologous blood, 40% and 70%, respectively. These volumes were most similar to the clinical scenario of combined ICH and IVH, demonstrating that this novel rat model is a promising starting point for future ICH+IVH research.


Subject(s)
Cerebral Hemorrhage/pathology , Cerebral Ventricles/pathology , Hydrocephalus/pathology , Animals , Blood Volume/physiology , Brain Edema/etiology , Brain Edema/surgery , Cerebral Hemorrhage/surgery , Cerebral Ventricles/surgery , Hydrocephalus/surgery , Magnetic Resonance Imaging , Male , Rats, Wistar
3.
Cancer Gene Ther ; 19(2): 126-34, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22095385

ABSTRACT

Oncolytic adenoviruses are a promising treatment alternative for many advanced cancers, including colorectal cancer. However, clinical trials have demonstrated that single-agent therapy in advanced tumor masses is rarely curative. Poor spreading of the virus through tumor tissue is one of the major issues limiting efficacy. As oncolytic viruses kill preferentially cancer cells, high extracellular matrix (ECM) content constitutes potential barriers for viral penetration within tumors. In this study, the ECM-degrading proteases relaxin, hyaluronidase, elastase and macrophage metalloelastase (MME) were tested for their antitumor efficacy alone and in combination with oncolytic adenovirus. MME improved the overall antitumor efficacy of oncolytic adenovirus in subcutaneous HCT116 xenografts. In a liver metastatic colorectal cancer model, intra-tumoral treatment of primary tumors from HT29 cells with MME monotherapy or with oncolytic adenovirus inhibited tumor growth. Combination therapy showed no increased mortality in comparison with either monotherapy alone. Contradictory results of effects of MME on tumorigenesis and metastasis formation have been reported in the literature. This study demonstrates for the first time in a metastatic animal model that MME, as a monotherapy or in combination with oncolytic virus, does not increase tumor invasiveness. Co-administration of MME and oncolytic adenovirus may be a suitable approach for further optimization aiming at clinical applications for metastatic colorectal cancer.


Subject(s)
Adenoviridae/physiology , Colorectal Neoplasms/therapy , Matrix Metalloproteinase 12/pharmacology , Oncolytic Virotherapy/methods , Animals , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/pathology , Colorectal Neoplasms/virology , Combined Modality Therapy , Female , HCT116 Cells , HT29 Cells , Humans , Injections, Intralesional , Mice , Mice, Nude , Mice, SCID , Neoplasm Metastasis , Treatment Outcome , Virus Replication/drug effects , Xenograft Model Antitumor Assays
4.
Neuroscience ; 153(1): 175-81, 2008 Apr 22.
Article in English | MEDLINE | ID: mdl-18367342

ABSTRACT

The blood-brain barrier (BBB) is the principal regulator of blood-borne substance entry into the brain parenchyma. Therefore, BBB leakage, which leads to cerebral edema and influx of toxic substances, is common in pathological conditions such as cerebral ischemia, inflammation, trauma, and tumors. The leakage of BBB after ischemia-reperfusion injury has long been considered to be biphasic, although a considerable amount of discrepancies as for the timing of the second opening does exist among the studies. This led us to evaluate systematically and quantitatively the dynamics of BBB leakage in a rat model of 90-min ischemia-reperfusion, using gadolinium-enhanced (small molecule) magnetic resonance imaging and fluorescent dye Evans Blue (large molecule). BBB leakage was assessed at the following time points after reperfusion: 25 min, 2, 4, 6, 12, 18, 24, 36, 48, and 72 h, and 1, 2, 3, 4, and 5 weeks. We observed BBB leakage for both gadolinium and Evans Blue as early as 25 min after reperfusion. Thereafter, BBB remained open for up to 3 weeks for Evans Blue and up to 5 weeks for gadolinium. Our results show that BBB leakage after ischemia-reperfusion injury in the rat is continuous and long-lasting, without any closure up to several weeks. This is the first systematic and extensive study fully demonstrating BBB leakage dynamics following transient brain ischemia and the findings are of major clinical and experimental interest.


Subject(s)
Blood-Brain Barrier/physiopathology , Brain Edema/physiopathology , Brain Ischemia/physiopathology , Reperfusion Injury/physiopathology , Animals , Blood-Brain Barrier/pathology , Brain Edema/etiology , Brain Edema/pathology , Brain Ischemia/complications , Brain Ischemia/pathology , Cerebral Arteries/physiopathology , Cerebrovascular Circulation/physiology , Coloring Agents/pharmacokinetics , Disease Models, Animal , Evans Blue/pharmacokinetics , Gadolinium/pharmacokinetics , Magnetic Resonance Imaging , Male , Rats , Rats, Wistar , Reperfusion Injury/complications , Reperfusion Injury/pathology , Time Factors
5.
Magn Reson Med ; 55(3): 592-7, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16453315

ABSTRACT

Deletion of the majority of the first intron of the Col1a1 gene in mice leads to decreased type I collagen synthesis and content in the aortic wall. In 54% of cases, mice homozygous for the Col1a1 mutation die of thoracic hemorrhage by the age of 18 months. It is unknown whether the fatal bleeding results from an acute dissection of the aortic wall or a gradually developing dilatation of the medial layer prior to rupture. We optimized high-resolution MRI methods using a 4.7 T MR scanner to obtain in vivo images of the entire mouse aorta. The MR images were acquired in three imaging planes using gradient echo, spin echo, and spin echo with inversion recovery pulse sequences with a maximum in-plane resolution of 68 x 68 microm and acquisition times less than 10 min. In five Col1a1 mutated mice aged 16 months, the MR images showed no signs of aneurysmal dilatation, wall defects, or former dissection, suggesting that the mechanism for aortic rupture is an acute dissection of the aortic medial layer. Cerebral arteries were imaged using a three-dimensional time of fight pulse sequence. The resolution of 73 x 73 x 94 microm showed normal cerebral arteries. Histology showed a 22% thinner cerebral artery wall in Col1a1 mutated mice.


Subject(s)
Aorta/pathology , Aortic Rupture/genetics , Cerebral Arteries/pathology , Collagen Type I/genetics , Magnetic Resonance Imaging/methods , Animals , Collagen Type I, alpha 1 Chain , Dilatation, Pathologic , Mice , Mutation
6.
Phys Med Biol ; 48(17): 2895-906, 2003 Sep 07.
Article in English | MEDLINE | ID: mdl-14516107

ABSTRACT

Polymer gels have been reported as a new, potential tool for dosimetry in mixed neutron-gamma radiation fields. In this work, BANG-3 (MGS Research Inc.) gel vials from three production batches were irradiated with 6 MV photons of a Varian Clinac 2100 C linear accelerator and with the epithermal neutron beam of the Finnish boron neutron capture therapy (BNCT) facility at the FiR 1 nuclear reactor. The gel is tissue equivalent in main elemental composition and density and its T2 relaxation time is dependent on the absorbed dose. The T2 relaxation time map of the irradiated gel vials was measured with a 1.5 T magnetic resonance (MR) scanner using spin echo sequence. The absorbed doses of neutron irradiation were calculated using DORT computer code, and the accuracy of the calculational model was verified by measuring gamma ray dose rate with thermoluminescent dosimeters and 55Mn(n,gamma) activation reaction rate with activation detectors. The response of the BANG-3 gel dosimeter for total absorbed dose in the neutron irradiation was linear, and the magnitude of the response relative to the response in the photon irradiation was observed to vary between different gel batches. The results support the potential of polymer gels in BNCT dosimetry, especially for the verification of two- or three-dimensional dose distributions.


Subject(s)
Boron Neutron Capture Therapy/instrumentation , Gels , Polymers , Radiometry/instrumentation , Radiometry/methods , Radiotherapy Planning, Computer-Assisted/instrumentation , Boron Neutron Capture Therapy/methods , Dose-Response Relationship, Radiation , Equipment Failure Analysis , Neutrons/therapeutic use , Radiation Dosage , Radiometry/standards , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/methods , Reproducibility of Results , Sensitivity and Specificity
7.
Appl Radiat Isot ; 46(9): 855-8, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7581292

ABSTRACT

Studying the biodistribution of boronated compounds for B neutron capture therapy (BNCT) requires the accurate detection of low levels of boron (10B) in biological samples. Proton induced gamma-ray emission analysis (PIGE) of 10B was found to be viable in a study of low density lipoprotein (LDL), in tissue and blood samples. However, the method is sensitive to Na present in the samples and can therefore not be used for accurate measurements of 10B concentrations below 5 ppm in samples containing Na. PIGE can be considered to be an appropriate reference method for chemical B analysis. The factor analytical method presented here is the most objective way to separate Na and B peaks from each other, and the factorizing method can be applied in different forms of spectral analysis.


Subject(s)
Boron/analysis , Boron/blood , Boron/pharmacokinetics , Gamma Rays , Humans , Isotopes , Kidney/chemistry , Liver/chemistry , Protons , Reference Standards , Spectrometry, Gamma/methods , Spleen/chemistry , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...